These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J. Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [Abstract] [Full Text] [Related]
4. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR. Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [Abstract] [Full Text] [Related]
7. [Factors determining the choice between mastectomy and conservative treatment in the Côte-d'Or department (France). The Côte-d'Op6 register of gynecological cancers]. Chaplain G, Barillot I, Cuisenier J, Milan C, Collin F, Dusserre P, Michiels R, Le Dorze C. Bull Cancer; 1994 Apr; 81(4):303-10. PubMed ID: 7703547 [Abstract] [Full Text] [Related]
8. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases? Sautter-Bihl ML, Sauer R. Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867 [No Abstract] [Full Text] [Related]
9. Long-term follow-up of patients with node-negative breast cancer treated only by regional therapy. McBride CM, Boddie AW, Brown B. Surgery; 1992 Oct; 112(4):689-93. PubMed ID: 1411939 [Abstract] [Full Text] [Related]
10. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field. Stranzl H, Peintinger F, Ofner P, Prettenhofer U, Mayer R, Hackl A. Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510 [Abstract] [Full Text] [Related]
12. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F. Cancer; 2005 Jul 01; 104(1):20-9. PubMed ID: 15912514 [Abstract] [Full Text] [Related]
13. Mortality impact of less-than-standard therapy in older breast cancer patients. Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA. J Am Coll Surg; 2008 Jan 01; 206(1):66-75. PubMed ID: 18155570 [Abstract] [Full Text] [Related]
15. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital. Dinshaw KA, Sarin R, Budrukkar AN, Shrivastava SK, Deshpande DD, Chinoy RF, Badwe R, Hawaldar R. J Surg Oncol; 2006 Aug 01; 94(2):105-13. PubMed ID: 16847919 [Abstract] [Full Text] [Related]
18. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Cancer; 2006 Jan 01; 106(1):35-41. PubMed ID: 16333848 [Abstract] [Full Text] [Related]
20. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients. Cutuli B, Cottu PH, Guastalla JP, Mechin H, Costa A, Jourdan R. Breast Cancer Res Treat; 2006 Jan 01; 95(1):55-64. PubMed ID: 16261401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]